Molecule intelOpportunity: ModerateEssential

Loperamide

56 brands · 44 companies · product forms

ATC: A07DA03

Opportunity snapshot

Launch attractiveness
39
Market saturation
81
Price room
100
Regulatory risk
0
56
brands
44
companies
Rs 294.14
median price
43
price points
9.95x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 40.46
MedianRs 294.14
Most expensiveRs 402.76
Spread9.95×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 9.95x across 43 trusted points (Rs 40.46-402.76). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Loperamide — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(19) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

44 canonical companies and 56 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 9.95x across 43 trusted points (Rs 40.46-402.76). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.